|
2023
|
Invention
|
Method for synthesizing deucravacitinib. Provided in the present application is a method for synt... |
|
2021
|
Invention
|
Process of making roxadustat.
A process of making Roxadustat of the following formula:
A proce... |
|
|
Invention
|
Process of making roxadustat. 12020 alkyl group, and PG is a protective group. |
|
2020
|
Invention
|
Crystalline and amorphous solids of relugolix and preparation method therefor. The present invent... |
|
|
Invention
|
Method for preparing pharmaceutical intermediate of relugolix. Disclosed are a synthetic scheme f... |
|
|
Invention
|
Crystalline form of di-p-toluoyl-l-tartrate of upadacitinib. The present application provides a u... |
|
|
Invention
|
Upadacitinib salt compound and preparation method therefor. The present application provides a up... |
|
|
Invention
|
Crystalline forms of antidepressant drug sage-217 and preparation method therefor.
The present a... |
|
|
Invention
|
Crystal forms of antidepressant drug sage-217 and preparation method therefor. The present applic... |
|
2019
|
Invention
|
Synthesis methods for upadacitinib and intermediate thereof. The present disclosure relates to a ... |
|
|
Invention
|
Synthesis methods for upadacitinib and intermediate thereof. 11 is an open chain or cyclic amine ... |
|
|
Invention
|
Amorphous and crystalline forms of valbenazine salt.
The present invention relates to amorphous ... |
|
|
Invention
|
Amorphous and crystalline forms of valbenazine salt. The present invention relates to amorphous a... |
|
|
Invention
|
Processes to produce brivaracetam.
The present invention provides a scalable synthesis of enanti... |
|
|
Invention
|
Processes to produce brivaracetam. The present invention provides a scalable synthesis of enantio... |
|
2018
|
Invention
|
Processes to produce elagolix. The present invention relates to a scalable process for the making... |
|
|
Invention
|
Processes to produce acalabrutinib. The present invention relates to a method for preparing the c... |
|
|
Invention
|
Crystalline forms of trisodium supramolecular complex comprising valsartan and ahu-377 and method... |
|
|
Invention
|
Venetoclax crystal forms and preparation method therefor. Venetoclax crystal forms and a preparat... |
|
2016
|
Invention
|
Ketolide antibiotics intermediate, preparation method therefor, and application thereof. A ketoli... |
|
|
Invention
|
Processes to produce brivaracetam. A stereoselective process for providing a scalable synthesis o... |
|
|
Invention
|
Ahu-377 intermediates and method for preparing ahu-377 and ahu-377 intermediates. Disclosed are A... |
|
2015
|
Invention
|
Crystalline form iv of trisodium supramolecular complex comprising valsartan and ahu-377 and meth... |
|
|
Invention
|
Salts and crystalline forms of 6-acetyl-8-cyclopentyl-5-methyl-2((5-(piperazin-1-yl)pyridin-2-yl)... |
|
2014
|
Invention
|
Salts and co-crystals of lesinurad. Novel salts and cocrystals of lesinurad, processes for their ... |
|
|
Invention
|
Novel salts and co-crystals of lesinurad. Novel salts and cocrystals of lesinurad, processes for ... |
|
|
Invention
|
Crystalline form i of ibrutinib. Crystalline Form I of ibrutinib, processes for its preparation, ... |
|
|
Invention
|
Crystalline forms of lesinurad and its sodium salt. Novel crystalline forms of lesinurad and its ... |
|
2013
|
Invention
|
Method for preparing aliphatic phosphate ester having protected hydroxyl with optical activity. T... |
|
|
Invention
|
Gout drug lesinurad preparation method, and lesinurad intermediate. Provided are a novel Lesinura... |
|
|
Invention
|
Carfilzomib intermediate and preparation method therefor, and preparation method for carfilzomib.... |
